1. Home
  2. SQNS vs IMUX Comparison

SQNS vs IMUX Comparison

Compare SQNS & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SQNS
  • IMUX
  • Stock Information
  • Founded
  • SQNS 2003
  • IMUX 2016
  • Country
  • SQNS France
  • IMUX United States
  • Employees
  • SQNS N/A
  • IMUX N/A
  • Industry
  • SQNS Semiconductors
  • IMUX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SQNS Technology
  • IMUX Health Care
  • Exchange
  • SQNS Nasdaq
  • IMUX Nasdaq
  • Market Cap
  • SQNS 85.7M
  • IMUX 86.3M
  • IPO Year
  • SQNS 2011
  • IMUX N/A
  • Fundamental
  • Price
  • SQNS $3.11
  • IMUX $0.98
  • Analyst Decision
  • SQNS Strong Buy
  • IMUX Strong Buy
  • Analyst Count
  • SQNS 1
  • IMUX 6
  • Target Price
  • SQNS $7.50
  • IMUX $12.67
  • AVG Volume (30 Days)
  • SQNS 105.8K
  • IMUX 1.0M
  • Earning Date
  • SQNS 02-11-2025
  • IMUX 02-20-2025
  • Dividend Yield
  • SQNS N/A
  • IMUX N/A
  • EPS Growth
  • SQNS N/A
  • IMUX N/A
  • EPS
  • SQNS 1.65
  • IMUX N/A
  • Revenue
  • SQNS $30,555,000.00
  • IMUX N/A
  • Revenue This Year
  • SQNS $10.14
  • IMUX N/A
  • Revenue Next Year
  • SQNS $8.54
  • IMUX N/A
  • P/E Ratio
  • SQNS $1.93
  • IMUX N/A
  • Revenue Growth
  • SQNS N/A
  • IMUX N/A
  • 52 Week Low
  • SQNS $0.85
  • IMUX $0.92
  • 52 Week High
  • SQNS $7.33
  • IMUX $2.11
  • Technical
  • Relative Strength Index (RSI)
  • SQNS 50.30
  • IMUX 44.34
  • Support Level
  • SQNS $3.00
  • IMUX $0.94
  • Resistance Level
  • SQNS $3.64
  • IMUX $1.02
  • Average True Range (ATR)
  • SQNS 0.22
  • IMUX 0.06
  • MACD
  • SQNS -0.01
  • IMUX 0.00
  • Stochastic Oscillator
  • SQNS 34.78
  • IMUX 44.96

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its solutions incorporate baseband processor and radio frequency, transceiver integrated circuits, along with its proprietary signal processing techniques, algorithms, and software stacks. The company's solutions serve as the core wireless broadband communications platform in devices, including smartphones, USB dongles, portable routers, laptops, netbooks, tablets, and other consumer multimedia and industrial devices. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: